In our review just published in Journal of Clinical Medicine, we discuss a series of promising metabolites revealed through untargeted metabolomics of serum, faecal, urine and biopsy samples, such as lipids or aminoacids.
- Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease. Bauset C, Gisbert-Ferrándiz L, Cosín-Roger J. J Clin Med. 2021 Feb 6;10(4):622. doi: 10.3390/jcm10040622.